Evidence map›Paper›PMID 22819969›Full record

ArticlePharmacology, biochemistry, and behavior2012

Neonatal fibroblast growth factor treatment enhances cocaine sensitization.

Sarah M Clinton, Cortney A Turner, Shelly B Flagel, Danielle N Simpson, Stanley J Watson, Huda Akil

Open access · greenAbstract read
In one paragraph

Article in Pharmacology, biochemistry, and behavior, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Resilience to Stress: Lessons from Rodents about Nature versus Nurture.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2022
    Review
  5. Review
  6. Article
  7. Article
  8. Inhibition of FGF Receptor-1 Suppresses Alcohol Consumption: Role of PI3 Kinase Signaling in Dorsomedial Striatum.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Fibroblast Growth Factor 2 in the Dorsomedial Striatum Is a Novel Positive Regulator of Alcohol Consumption.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. FGF2 is a target and a trigger of epigenetic mechanisms associated with differences in emotionality: partnership with H3K9me3.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sarah M ClintonDepartment of Psychiatry and Behavioral Neurobiology, University of Alabama-Birmingham, Birmingham, AL35294, USA. clintons@uab.edu
Cortney A Turner
Shelly B Flagel
Danielle N Simpson
Stanley J Watson
Huda Akil
University of Michigan–Ann Arbor · USUniversity of Alabama at Birmingham · US

Funding

FOREBRAIN OVEREXPRESSION OF A STRESS-RELATED GENEP01DA021633 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI AKIL, HUDA · 2007 to 2011
$6.2M
Neurodevelopmental Underpinnings of Rodent Anxiety and Depressive BehaviorR00MH085859 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CLINTON, SARAH M · 2011 to 2013
$705k
NIDA NIH HHS 5P01DA021633-02NIDA NIH HHS P01 DA021633NIMH NIH HHS R00 MH085859PHS HHS NIMH R00 MH085859-03
6 · The paper itself

Abstract

Growth factors are critical in neurodevelopment and neuroplasticity, and recent studies point to their involvement in addiction. We previously reported increased levels of basic fibroblast growth factor (FGF2) in high novelty/drug-seeking rats (bred high responders, bHR) compared to low novelty/drug-seeking rats(bred low responders, bLRs). The present study asked whether an early life manipulation of the FGF system(a single FGF2 injection on postnatal day 2) can impact cocaine sensitization and associated neurobiological markers in adult bHR/bLR animals. Neonatal FGF2- and vehicle-treated bHR/bLR rats were sensitized to cocaine(7 daily injections, 15 mg/kg/day, i.p.) in adulthood. Neonatal FGF2 markedly increased bLRs' typically low psychomotor sensitization to cocaine (day 7 locomotor response to cocaine), but had little effect on bHRs' cocaine sensitization. Gene expression studies examined dopaminergic molecules as well as FGF2 and the FGFR1 receptor in cocaine naïve animals, to investigate possible neurobiological alterations induced by neonatal FGF2 exposure that may influence behavioral response to cocaine. bLRs showed decreased tyrosine hydroxylase in the ventral tegmental area (VTA), decreased D1 and increased D2 receptor expression in the nucleus accumbens core, as well as decreased FGF2 in the VTA, substantia nigra, accumbens core, and caudate putamen compared to bHRs. Neonatal FGF2 selectively increased D1 receptor and FGF2 mRNA in the accumbens core of bLRs, which may contribute to their heightened cocaine sensitization. Our results suggest increased FGF2 in the mesodopaminergic circuit (as in baseline bHRs and neonatal FGF2-exposed bLRs vs. baseline bLRs) enhances an individual's susceptibility to cocaine sensitization and may increase vulnerability to drug seeking and addiction.

Indexed as

AnimalsAnimals, NewbornBrainCocaine-Related DisordersDrug-Seeking BehaviorExploratory BehaviorFemaleFibroblast Growth Factor 2Gene ExpressionMaleMotor ActivityRatsRats, Sprague-DawleyReceptors, Dopamine D1Receptors, Dopamine D2RNA, MessengerFibroblast Growth Factor 2Receptors, Dopamine D1Receptors, Dopamine D2RNA, Messenger

Identifiers

PMID22819969
PMCPMC3496829
OpenAlexW2029262422

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.